Endometrial cancer recurrent – Trials in Disease – Overview of Information and Clinical Research

Cancer research · Endometrial cancer

We have identified four ongoing clinical trials investigating new treatments for recurrent endometrial cancer.

The page lists four ongoing clinical trials investigating novel therapeutic strategies for recurrent endometrial cancer in patients who have previously received platinum‑based chemotherapy. The studies involve antibody‑drug conjugates, immunotherapy combinations, PARP inhibitors and maintenance therapy and are conducted across several European countries, with Spain as the most active site.

These trials offer patients with metastatic or relapsed endometrial carcinoma access to experimental therapies that may improve survival or quality of life, and they contribute to the growing evidence base for targeted and immune‑based treatments in gynecologic cancers.

Evidence level: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.

Original source

Related signals